Healthcare merger and acquisition activity has regained momentum, ending 2022 with 53 announced transactions and more than $45 billion in total transacted revenue, reports Kaufman Hall.
The healthcare consulting firm’s latest analysis of healthcare transactions shows a rebound in M&A activity after COVID-19 dampened enthusiasm over the last couple of years. The total number of healthcare transactions remains below pre-pandemic levels, but there are clear signs that the momentum will continue into 2023, RevCycleIntelligence writes.
Firm chair Ken Kaufman noted in a recent blog post, “this is a transformative period in American healthcare, when hospital organizations are faced with the need to fundamentally reinvent themselves both financially and clinically.” Severe financial pressures and the “unpausing” of initiatives put off during the height of the pandemic will prompt more transactions this year, analysis authors write. Read more.
